Wednesday, July 8, 2026

biotech · Attention Deficit Hyperactivity Disorder · Vascular Ehlers-Danlos Syndrome · AYTU

AYTU BIOPHARMA

AYTU BIOPHARMA trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Denver, USA HQ
2015 Founded
105 Employees
Public company Type
AYTU · NYSE Ticker
Company details
Status
Public
HQ
Denver, USA
Founded
2015
Employees
105
Programs
3
Drugs
5
Patents
4
Intelligence · Clinical Trials

AYTU BIOPHARMA clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to AYTU BIOPHARMA programs — each row shows trial ID, program name, phase, status, and indication.

AYTU BIOPHARMA trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for AYTU BIOPHARMA.

  1. Antioxidant — Unknown

    Clinical update
  2. Enzastaurin — Phase 3

    Clinical update
  3. ADZENYS XR-ODT — Approved

    Clinical update

Trial registry

3 studies
  1. NCT04758260

    Antioxidant

    Unknown terminated other

    Compare the sORP Rate in Sperm Samples, Obtained by the Mioxsys System, Before and After 2.5 Months Antioxidant Men Supplements Treatment (Fertybiotic Man)

    CT.gov ↗